Back to Search Start Over

Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.

Authors :
Gromisch ES
Turner AP
Neto LO
Ruiz JA
Lo AC
Agresta T
Foley FW
Source :
International journal of MS care [Int J MS Care] 2023 Jan-Feb; Vol. 25 (1), pp. 15-19. Date of Electronic Publication: 2022 Sep 07.
Publication Year :
2023

Abstract

Background: The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.<br />Methods: Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.<br />Results: At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.<br />Conclusions: These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.<br />Competing Interests: FINANCIAL DISCLOSURES: The authors declare no conflicts of interest.<br /> (© 2023 Consortium of Multiple Sclerosis Centers.)

Details

Language :
English
ISSN :
1537-2073
Volume :
25
Issue :
1
Database :
MEDLINE
Journal :
International journal of MS care
Publication Type :
Academic Journal
Accession number :
36711223
Full Text :
https://doi.org/10.7224/1537-2073.2021-126